Escherichia coli ST131 Drives Carbapenem Use for E. Coli Bloodstream Infections

By afschroeder • March 9, 2026

Mackow NA, Shao W, Ge L, Komarow L, Jiang J, Boutzoukas A, Chen L, Garcia-Diaz J, Herc ES, Doi Y, Arias CA, Albin O, Saade E, Miller LG, Jacob JT, Satlin MJ, Krsak M, Huskins WC, Dhar S, Shelburne SA, Hill C, Alby K, Sadler JM, Hill BM, Greenwood-Quaintance KE, Schmidt-Malan SM, Patel R, Fowler VG Jr, Tamma PD, Kreiswirth BN, van Duin D; Antibacterial Resistance Leadership Group. Escherichia coli ST131 Drives Carbapenem Use for E. Coli Bloodstream Infections. Clin Infect Dis. 2026 Mar 6:ciag160. doi: 10.1093/cid/ciag160. Epub ahead of print. PMID: 41795867.

Tags: bacteremia, carbapenems, ceftriaxone resistance, E. coli, Harbor UCLA, Infectious Diseases, Publications, ST131

The future of home oxygen therapy

Holland AE, Krishnan JA, Lacasse Y, Gomes H, Björklund F, Casaburi R, de Andrade J, Eakin MN, Hui D, Jacobs SS, Kawachi S, Khor YH,[...]

Emerging quantitative CCTA imaging biomarkers for cardiovascular risk stratification: a narrative review

Mora R, Irannejad K, Abbas N, Mogga P, Iskander B, Hubbard L, Roy S, Lakshmanan S, Budoff M, Krishnan S. Emerging quantitative CCTA imaging biomarkers[...]

Association between depressive symptoms and thoracic aortic calcification, and their independent and joint prognostic value for incident atherosclerotic cardiovascular disease in the MESA cohort

Arai D, White Q, Ichikawa K, McClelland RL, Johnson WC, Yabuki M, Hansen S, Budoff MJ. Association between depressive symptoms and thoracic aortic calcification, and[...]